As a seasoned innovator with a Ph.D. in Life Sciences, I pioneered advances in respiratory, cardiovascular, fibrosis, and oncology.
With over a decade of entrepreneurial expertise, I bring a wealth of experience from building biotech ventures, innovation programs and funding initiatives within five renowned international universities (Toronto, Yale, McMaster, Western/Ivey, and Florida State).
My career is marked by significant achievements in strategic leadership, most notably spearheading the National adMare BioInnovation Therapeutics (Tx) Accelerator in collaboration with MaRS in Canada.
I am very passionate about translating discoveries into life-changing treatments and technologies and working with innovation pioneers.
This made me eager to cultivate my own practice, one that would effectively intersect my expertise with my respective interests. I believe that what makes a creative business thrive is the passion that drives it.
Caroline is an experienced investor relations professional with a proven track record in supporting early-stage and clinical-stage biotech companies, as well as those with commercialized products. Over the course of her career, she has led investor relations efforts at small to mid-cap biotech companies, served as an Analyst at a venture capital firm, and held the position of Blavatnik Fellow at Yale.
Her expertise spans a variety of critical areas, including developing investor targeting and outreach strategies to raise capital, conducting competitive intelligence research, and creating impactful investor pitch decks.
